RxDoctor Payments Data

Monica Silva, NP

Family · East Moriches, NYNPI 1831476647

Payments from drug & device makers

$2,631in general payments, 2019–2025

Across 153 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$714
  • Medtronic$470
  • Abbott$304
  • Amarin Pharma, Inc.$282
  • Lilly USA, LLC$194
  • Corcept Therapeutics$135
  • plus $532 from 13 others

What the payments were for

  • Food & beverage$2,631100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,631 in reported general payments places this provider in the 85th percentile of 8,883 family providers in New York.

See all family providers in New York

Medicare billing

Part B allowed, 2024
$19,152
Medicare patients
43
Services billed
727

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide106$188,494
JardianceEmpagliflozin74$103,244
MounjaroTirzepatide59$101,295
TrulicityDulaglutide41$69,233
RybelsusSemaglutide30$63,042
FarxigaDapagliflozin Propanediol28$37,794
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$4,623
Metformin Hcl ErMetformin Hcl223$3,143
SynthroidLevothyroxine Sodium27$2,366
Levothyroxine Sodium168$1,975
Nano 2nd Gen Pen NeedlePen Needle, Diabetic25$1,667
Nateglinide20$1,542
Pioglitazone Hcl30$277
Vitamin D2Ergocalciferol (Vitamin D2)32$226
Methimazole16$199

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$714$251,536136 claims
Lilly USA, LLCMounjaro, Trulicity$194$170,527100 claims
Boehringer IngelheimJardiance$106$103,24474 claims
AstraZenecaFarxiga$47$37,79428 claims
AbbVieSynthroid$17$2,36627 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$119$1,975168 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,883 family providers in New York.

Other family in East Moriches

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →